SCHEMBL4624400

SCHEMBL4624400

Cc1cccc(Cc2ccc(O)c(C(=O)O)c2)c1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HNF4A P41235 1/20 0.73
▸ KLKB1 P03952 1/20 0.72
▸ CTSB P07858 1/20 0.72
▸ MMP9 P14780 1/20 0.72
▸ DNMT1 P26358 1/20 0.72
▸ DNMT3B Q9UBC3 1/20 0.72
▸ DNMT3L Q9UJW3 1/20 0.72
▸ DNMT3A Q9Y6K1 1/20 0.72
▸ ACMSD Q8TDX5 3/20 0.60
▸ CSNK2A1 P68400 1/20 0.59
▸ LCK P06239 2/20 0.53
▸ KAT8 Q9H7Z6 2/20 0.50
▸ DVL1 O14640 1/20 0.50
▸ MCL1 Q07820 2/20 0.49
▸ ALDH1A1 P00352 2/20 0.48
▸ KDM5B Q9UGL1 1/20 0.48
▸ HPGD P15428 1/20 0.48
▸ ALOX15 P16050 1/20 0.48
▸ HSD17B10 Q99714 1/20 0.48
▸ CDC25B P30305 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9651461 0.85 KLKB1 (0.79) HNF4AKLKB1CTSBMMP9DNMT1
SCHEMBL27396608 0.85 HNF4A (1.00) HNF4AKLKB1CTSBMMP9DNMT1
SCHEMBL5446640 0.85 HNF4A (1.00) HNF4AKLKB1CTSBMMP9DNMT1
SCHEMBL29414416 0.85 KLKB1 (1.00) HNF4AKLKB1CTSBMMP9DNMT1
SCHEMBL160646 0.85 KLKB1 (1.00) HNF4AKLKB1CTSBMMP9DNMT1
SCHEMBL11133452 0.83 HNF4A (0.96) HNF4AKLKB1CTSBMMP9DNMT1
SCHEMBL23265352 0.82 KLKB1 (0.79) HNF4AKLKB1CTSBMMP9DNMT1
SCHEMBL9769908 0.81 ACMSD (0.83) HNF4AKLKB1CTSBMMP9DNMT1
SCHEMBL9650118 0.81 PTPN1 (0.73) HNF4AKLKB1CTSBMMP9DNMT1
SCHEMBL7775844 0.79 KLKB1 (0.68) HNF4AKLKB1CTSBMMP9DNMT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107250107-B The crystal modifications of N- (2- (3- phenylcarbamido) phenyl) benzsulfamide and the recording materials for using the crystal modifications 日本曹达株式会社 2019-08-09 — — CN disclosed
US-10265984-B2 Crystalline modification of N-(2-(3-phenylureido)phenyl)benzenesulfonamide and recording material using same NIPPON SODA CO., LTD. (JP) 2019-04-23 — — US disclosed
US-20180022136-A1 CRYSTALLINE MODIFICATION OF N-(2-(3-PHENYLUREIDO)PHENYL)BENZENESULFONAMIDE AND RECORDING MATERIAL USING SAME NIPPON SODA CO., LTD. (JP) 2018-01-25 — — US disclosed
CN-107250107-A N‑(2‑(3 phenylcarbamidos)Phenyl)The crystal modifications of benzsulfamide and the recording materials using the crystal modifications 日本曹达株式会社 2017-10-13 — — CN disclosed
US-9221989-B2 Tamper evident documents and inks P.H. GLATFELTER COMPANY (US) 2015-12-29 — — US disclosed
CN-104797429-A Recording material using non-phenolic compound NIPPON SODA CO 2015-07-22 — — CN disclosed
US-20150064419-A1 TAMPER EVIDENT DOCUMENTS AND INKS PROVIDENCIA USA, INC. 2015-03-05 — — US disclosed
WO-2015017494-A1 TAMPER EVIDENT DOCUMENTS AND INKS P.H. GLATFELTER COMPANY (US) 2015-02-05 — — WO disclosed
US-20150037565-A1 TAMPER EVIDENT DOCUMENTS AND INKS GLATFELTER CORPORATION 2015-02-05 — — US disclosed
CN-102548768-B Recording material using phenolic compound NIPPON SODA CO 2014-06-25 — — CN disclosed
US-4956309-A LIGHT SENSITIVE ELEMENTS, RECEIVERS THE MEAD CORPORATION (US) 1990-09-11 — — US disclosed
EP-0380677-A1 FLUORAN COMPOUNDS AND COLOR-FORMING RECORDING MATERIALS CONTAINING SAME NIPPON SODA CO., LTD. (JP) 1990-08-08 — — EP disclosed
CN-1043204-A Be used to form the developer sheet of high density images MEAD CORP (US) 1990-06-20 — — CN disclosed
EP-0372927-A2 Developer sheet and imaging means, both for forming images THE MEAD CORPORATION (US) 1990-06-13 — — EP disclosed
EP-0338808-A2 Alkyl salicylate resin for carbonless copy paper and imaging use SCHENECTADY INTERNATIONAL, INC. (US) 1989-10-25 — — EP disclosed
EP-0162664-B1 IMAGING SYSTEMS, PROCESSES FOR IMAGING AND DEVELOPER SHEETS USEFUL THEREIN THE MEAD CORPORATION (US) 1989-09-13 — — EP disclosed
US-4587194-A MULTICOLOR THE MEAD CORPORATION (US) 1986-05-06 — — US disclosed
US-4554235-A Microencapsulated transfer imaging system employing developer sheet and discontinuous layer of thermoplastic pigment THE MEAD CORPORATION (US) 1985-11-19 — — US disclosed
US-4403051-A NONVISCOUS MIXTURE OF POLYVINYL ALCOHOL AND PULP KANZAKI PAPER MANUFACTURING COMPANY, LIMITED (JP) 1983-09-06 — — US disclosed
US-4199619-A REACTION ON BASE SHEET BETWEEN COLOR FORMER IN FORM OF MICROENCAPSULATED OILY CORE MATERIAL AND ORGANIC ACCEPTOR COATED WITH CAROBXYLIC LATEX ON BASE SHEET KANZAKI PAPER MANUFACTURING CO., LTD. (JP) 1980-04-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10265984-B2 Crystalline modification of N-(2-(3-phenylureido)phenyl)benzenesulfonamide and recording material using same PDXK, PRNP, UCK2 HNF4A 2177/4885KLKB1 2973/4885CTSB 1930/4885
US-20180022136-A1 CRYSTALLINE MODIFICATION OF N-(2-(3-PHENYLUREIDO)PHENYL)BENZENESULFONAMIDE AND RECORDING MATERIAL USING SAME PDXK, PRNP, UCK2 HNF4A 2177/4885KLKB1 2973/4885CTSB 1930/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback